Sex­u­al ha­rass­ment in biotech hits home as Or­biMed’s Sam Isaly steps down in wake of STAT re­port

Two days af­ter Or­biMed gen­er­al man­ag­er Sam Isaly was hit by a scathing take­down by STAT writer Dami­an Garde out­lin­ing the fi­nancier’s pref­er­ences for on-the-job porn and a habit of ver­bal­ly abus­ing fe­male staffers, he’s gone.

Or­biMed, a glob­al biotech in­vestor, de­cid­ed to make it all sound like a rou­tine re­tire­ment for the 72-year-old Isaly, an­nounc­ing that he was step­ping down “pur­suant to years-long suc­ces­sion plan­ning dis­cus­sions.” Ear­li­er they brought in lawyers to look in­to the charges.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER